Research graph
References from Effect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism. Local targets link to admitted publications; unresolved targets remain external evidence.
Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence
10.1007/s001250100020 · 2001 · External reference
Postprandial hyperglycemia and diabetes complications: is it time to treat?
10.2337/diabetes.54.1.1 · 2005 · External reference
Prevention of type 2 diabetes by diet and lifestyle modification
10.1080/07315724.2005.10719479 · 2005 · External reference
A systematic review of drug therapy to delay or prevent type 2 diabetes
10.2337/diacare.28.3.736 · 2005 · External reference
Antidiabetic agents in subjects with mild dysglycaemia: prevention or early treatment of type 2 diabetes?
10.1016/j.diabet.2006.11.005 · 2007 · External reference
Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance
10.1016/s0140-6736(09)60222-1 · 2009 · External reference
Effect of valsartan on the incidence of diabetes and cardiovascular events
10.1056/nejmoa1001121 · 2010 · External reference
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study
10.1016/s0140-6736(10)60746-5 · 2010 · External reference
Effect of ramipril on the incidence of diabetes
10.1056/nejmoa065061 · 2006 · External reference
Effect of nateglinide on the incidence of diabetes and cardiovascular events
10.1056/nejmoa1001122 · 2010 · External reference
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
10.1016/s0140-6736(02)08905-5 · 2002 · External reference
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial
10.1001/jama.290.4.486 · 2003 · External reference
Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.)
10.1021/jf010567e · 2001 · External reference
Glycosidase inhibitors: update and perspectives on practical use
10.1093/glycob/cwg090 · 2003 · External reference
Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats
10.3177/jnsv.50.161 · 2004 · External reference
Sugar-mimicking glycosidase inhibitors: bioactivity and application
10.1007/s00018-008-8522-3 · 2009 · External reference
Determination of 1-deoxynojirimycin in mulberry leaves using hydrophilic interaction chromatography with evaporative light scattering detection
10.1021/jf0306901 · 2004 · External reference
Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans
10.1021/jf062680g · 2007 · External reference
Report of the committee on the classification and diagnostic criteria of diabetes mellitus
2010 · External reference
An extract of black, green, and mulberry teas causes malabsorption of carbohydrate but not of triacylglycerol in healthy volunteers
10.1093/ajcn/84.3.551 · 2006 · External reference
Influence of mulberry leaf extract on the blood glucose and breath hydrogen response to ingestion of 75 g sucrose by type 2 diabetic and control subjects
10.2337/dc06-2120 · 2007 · External reference
Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients
10.1007/bf00277486 · 1988 · External reference
Mechanism for acute reduction of 1,5-anhydroglucitol in rats treated with diabetogenic agents
1990 · External reference
Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol
10.1016/0026-0495(92)90168-a · 1992 · External reference
Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control
10.1016/s0140-6736(96)90672-8 · 1996 · External reference
1,5-Anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes
10.2337/dc06-1910 · 2006 · External reference
α-Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis
10.2337/diacare.28.1.154 · 2005 · External reference
Generic and product-specific health claim processes for functional foods across global jurisdictions
10.1093/jn/138.6.1228s · 2008 · External reference
Health claim evidence requirements in Japan
10.1093/jn/138.6.1192s · 2008 · External reference
